Net Cash Provided by (Used in) Operating Activities |
-17.9K |
USD |
+88.5% |
Jul 31, 2023 |
Q2 2023 |
Net Cash Provided by (Used in) Financing Activities |
40K |
USD |
-89.1% |
Apr 30, 2023 |
Q1 2022 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Shares, Issued |
56.3M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-14.8K |
USD |
+90.8% |
Jul 31, 2023 |
Q2 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.14K |
USD |
-97.9% |
Oct 31, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
941K |
USD |
+15.8% |
Apr 30, 2023 |
Q1 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
-16.1% |
Apr 30, 2023 |
Q1 2022 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-1.9M |
USD |
-151% |
Jan 31, 2024 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
941K |
USD |
+15.8% |
Apr 30, 2023 |
Q1 2023 |
Additional Paid in Capital |
2.29M |
USD |
-49.3% |
Jan 31, 2024 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
96.6K |
USD |
-34.1% |
Apr 30, 2023 |
Q1 2023 |
Share-based Payment Arrangement, Expense |
250K |
USD |
|
Jan 31, 2024 |
Q4 2023 |
Interest Expense |
8.15K |
USD |
-1.35% |
Oct 31, 2023 |
Q3 2023 |